| Identification | Back Directory | [Name]
Benzamide, N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]- | [CAS]
2340388-72-7 | [Synonyms]
GLPG3312
Benzamide, N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]- | [Molecular Formula]
C23H21F2N5O3 | [MOL File]
2340388-72-7.mol | [Molecular Weight]
453.44 |
| Hazard Information | Back Directory | [Uses]
GLPG3312 (Compound 28) is a selective pan-SIK inhibitor with IC50 values of 2.0 nM, 0.7 nM and 0.6 nM for SIK1, SIK2 and SIK3, respectively. GLPG3312 exhibits anti-inflammatory and immunomodulatory activity in vitro on human primary myeloid cells and in vivo in mouse models. GLPG3312 has good oral bioavailability and can be used for research on inflammatory and immune diseases[1]. | [IC 50]
SIK1: 2.0 nM (IC50); SIK2: 0.7 nM (IC50); SIK3: 0.6 nM (IC50) | [References]
[1] Temal-Laib T, et al. Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312. J Med Chem. 2024 Jan 11;67(1):380-401. DOI:10.1021/acs.jmedchem.3c01428 |
|
|